TAL1 mediate imatinib-induced CML cell apoptosis via PI3K pathway

Chengwu Zeng

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-7 CML: Basic/Clinical

Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Junichiro Yuda (Depart,emt of Hematology, National Cancer Center Hospital East)

[PS2-7-8] TAL1 mediate imatinib-induced CML cell apoptosis via PI3K pathway

Chengwu Zeng^1,2, Yifan Wu^1,2, Yanyun Hu^1,2, Xibao Yu¹, Shaohua Chen¹, Yangqiu Li^1,2 (1.Institute of Hematology, School of Medicine, Jinan University, China, Guangzhou, People's Republic of China, 2.Key Laboratory for Regenerative Medicine of Ministry of Education, Guangzhou, People's Republic of China)

Abstract password authentication.
Password is written on a program and abstract book.